CCG
GILD icon

Catalina Capital Group’s Gilead Sciences GILD Stock Holding History

Catalina Capital Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$204K Buy
+1,461
New +$205K 0.12% 155
2025
Q1 		– Sell
-4,844
Closed -$447K – 264
2024
Q4 		$447K Buy
4,844
+987
+26% +$88.9K 0.15% 143
2024
Q3 		$323K Buy
+3,857
New +$294K 0.11% 196
2024
Q2 		– Sell
-2,786
Closed -$204K – 328
2024
Q1 		$204K Buy
+2,786
New +$214K 0.08% 256

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Catalina Capital Group's GILD Position: Q1 2026 in Review

Catalina Capital Group opened a new position in Gilead Sciences (GILD) in Q1 2026: 1,461 shares worth $204K. The stake represents 0.12% of the portfolio and ranks #155 among its holdings. This is a return to the name: Catalina Capital Group previously reported a position in GILD as recently as Q4 2024.

Catalina Capital Group first reported a position in GILD in Q1 2024 and has held it in 4 quarters since. The position peaked at $447K in Q4 2024. 2,320 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Catalina Capital Group held 1,461 shares of Gilead Sciences worth $204K as of Q1 2026.
  • Gilead Sciences was a new Catalina Capital Group position in Q1 2026.
  • Gilead Sciences made up 0.12% of Catalina Capital Group's portfolio in Q1 2026, its #155 holding.
  • Catalina Capital Group first reported a position in Gilead Sciences in Q1 2024 and has held it in 4 quarters since.
  • Catalina Capital Group's Gilead Sciences position peaked at $447K in Q4 2024.
  • 2,320 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Catalina Capital Group's 13F filing for Q1 2026, filed 23 Apr 2026.